Literature DB >> 9016428

Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

D B Matchar, G P Samsa, S J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9016428     DOI： 10.1007/bf02598998

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  38 in total

1.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.

Authors:  Daniel E Singer; Robert A Hughes; Daryl R Gress; Mary A Sheehan; Lynn B Oertel; Sue Ward Maraventano; Dyan Ryan Blewett; Bernard Rosner; J Philip Kistler
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

2.  US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy.

Authors:  L B Goldstein; A J Bonito; D B Matchar; P W Duncan; G P Samsa
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

3.  The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic.

Authors:  H I Bussey; R M Rospond; C M Quandt; G M Clark
Journal:  Pharmacotherapy       Date:  1989       Impact factor: 4.705

Review 4.  Antithrombotic therapy in atrial fibrillation.

Authors:  A Laupacis; G Albers; J Dalen; M Dunn; W Feinberg; A Jacobson
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

5.  Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.

Authors:  R F Ellis; M A Stephens; G B Sharp
Journal:  Am J Hosp Pharm       Date:  1992-02

6.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Authors:  E M Hylek; S J Skates; M A Sheehan; D E Singer
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

7.  The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Authors:  T R Lancaster; D E Singer; M A Sheehan; L B Oertel; S W Maraventano; R A Hughes; J P Kistler
Journal:  Arch Intern Med       Date:  1991-10

8.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Authors:  M D Ezekowitz; S L Bridgers; K E James; N H Carliner; C L Colling; C C Gornick; H Krause-Steinrauf; J F Kurtzke; S M Nazarian; M J Radford
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

9.  Cost-justification of a clinical pharmacist-managed anticoagulation clinic.

Authors:  D R Gray; S M Garabedian-Ruffalo; S D Chretien
Journal:  Drug Intell Clin Pharm       Date:  1985 Jul-Aug

10.  Anticoagulation clinics and the monitoring of anticoagulant therapy.

Authors:  R Charney; E Leddomado; D N Rose; V Fuster
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164
View more
  4 in total

1.  The outcomes of outcomes and effectiveness research: impacts and lessons from the first decade.

Authors:  D Stryer; S Tunis; H Hubbard; C Clancy
Journal:  Health Serv Res       Date:  2000-12       Impact factor: 3.402

2.  Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST).

Authors:  D B Matchar; G P Samsa; S J Cohen; E Z Oddone
Journal:  J Thromb Thrombolysis       Date:  2000-06       Impact factor: 2.300

3.  The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.

Authors:  J E Lafata; S A Martin; S Kaatz; R E Ward
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

4.  Patient and physician satisfaction with a telephone-based anticoagulation service.

Authors:  A D Waterman; G Banet; P E Milligan; A Frazier; E Verzino; B Walton; B F Gage
Journal:  J Gen Intern Med       Date:  2001-07       Impact factor: 5.128
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.